Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

© The Author 2015. Background. Concomitant use of rifamycins to treat or prevent tuberculosis can result in subtherapeutic concentrations of antiretroviral drugs. We studied the interaction of efavirenz with daily rifapentine and isoniazid in human immunodeficiency virus (HIV)-infected individuals r...

Saved in:

書目詳細資料
Main Authors:	Anthony T. Podany, Yajing Bao, Susan Swindells, Richard E. Chaisson, Janet W. Andersen, Thando Mwelase, Khuanchai Supparatpinyo, Lerato Mohapi, Amita Gupta, Constance A. Benson, Peter Kim, Courtney V. Fletcher
格式:	雜誌
出版:	2018
主題:	Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84943232683&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/54683
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention
由: Anthony T. Podany, et al.
出版: (2018)

One month of rifapentine plus isoniazid to prevent HIV-related Tuberculosis
由: Susan Swindells, et al.
出版: (2019)

Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
由: Jyoti S. Mathad, et al.
出版: (2022)

Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
由: Mathad J.S.
出版: (2023)

A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens
由: Nontiya Homkham, et al.
出版: (2018)

A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens
由: Homkham N., et al.
出版: (2017)

Isoniazid preventive therapy in HIV-infected pregnant and postpartum women
由: Amita Gupta, et al.
出版: (2020)

Efek pemberian Isoniazid pada Mycobacterium tuberculosis resisten Isoniazid terhadap produksi TNF Alfa dan Apoptosis Makrofag
由: , PANGEMANAN, Lisa, et al.
出版: (2005)

Does pregnancy affect the pharmacokinetics of efavirenz?
由: Andrew Hill, et al.
出版: (2018)

Does pregnancy affect the pharmacokinetics of efavirenz?
由: Andrew Hill, et al.
出版: (2018)

Does pregnancy affect the pharmacokinetics of efavirenz?
由: Hill A., et al.
出版: (2014)

Effect of phenytoin on the pharmacokinetics of efavirenz in rabbits
由: Gornganok Piboonpol
出版: (2013)

KINETICS STUDY IN EFAVIRENZ POLYMORPHIC TRANSFORMATION
由: Windhu Wardhana, Yoga

STABILITAS PIRAZINAMIDA DALAM CAMPURAN DENGAN ISONIAZID
由: BERTHA OKTARINA, 059812014
出版: (2003)

Efavirenz concentrations and probability of HIV replication in children
由: Nontiya Homkham, et al.
出版: (2018)

Efavirenz concentrations and probability of HIV replication in children
由: Nontiya Homkham, et al.
出版: (2018)

Efavirenz pharmacokinetics during pregnancy and infant washout
由: Regis Kreitchmann, et al.
出版: (2019)

Pharmacodynamic comparison of levofloxacin gatifloxacin and moxifloxacin against bacterial causing human sinusitis in an in vitro pharmacodynamic model
由: Apichat Phetmoreekul
出版: (2006)

Pharmacodynamic comparison of levofloxacin gatifloxacin and moxifloxacin against bacterial causing human sinusitis in an in vitro pharmacodynamic model
由: Apichat Phetmoreekul
出版: (2003)

Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 Weeks results
由: Weerawat Manosuthi, et al.
出版: (2018)

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
由: Tim R. Cressey, et al.
出版: (2018)

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
由: Cressey T., et al.
出版: (2017)

Effect of efavirenz on the Pharmacokinetics of Ketoconazole in HIV-infected patients
由: Somchai Sriwiriyajan
出版: (2006)

Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients
由: Somchai Sriwiriyajan, et al.
出版: (2006)

Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India
由: Blessed Winston Aruldhas, et al.
出版: (2020)

Clinical features and outcomes of isoniazid mono-resistant pulmonary tuberculosis
由: Nitipatana Chierakul, et al.
出版: (2018)

Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives
由: Nicholas J. White
出版: (2018)

Pharmacokinetic and pharmacodynamic interactions of mefloquine and dihydroartemisinin
由: Kesara Na-Bangchang, et al.
出版: (2018)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
由: Nicholas J. White, et al.
出版: (2018)

Pharmacokinetic and pharmacodynamic interactions of mefloquine and quinine
由: K. Na-Bangchang, et al.
出版: (2018)

Chirality. Clinical pharmacokinetic and pharmacodynamic considerations
由: Lee, E.J.D., et al.
出版: (2014)

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial
由: Jean Michel Molina, et al.
出版: (2018)

Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin
由: Weerawat Manosuthi, et al.
出版: (2018)

Pharmacokinetic interaction between efavirenz and itraconazole in HIV-infected patients
由: Kritsana Kongklao
出版: (2014)

Susceptibility of Rifampicin-Isoniazid Resistant Mycobacterium Tuberculosis Isolates Against Levofloxacin
由: Alvin Hartanto Kurniawan, et al.
出版: (2016)

Absence of relationship between isoniazid-induced hepatic disturbances and acetylator phenotype
由: Perpustakaan UGM, i-lib
出版: (1991)

Biosintesis 6,7 dehidroeritromisin melalui penghambatan reduksi enoil isoniazid
由: , HARYADI, Winarto, et al.
出版: (1999)

KATG GENE MUTATIONS IN ISONIAZID RESISTANT MYCOBACTERIUM TUBERCULOSIS CLINICAL ISOLATES
由: Rosa Pane, Elfira

Pharmacokinetics and pharmacodynamics of meropenem in children with severe infection
由: Kritsana Kongthavonsakul, et al.
出版: (2018)

Pharmacokinetics and pharmacodynamics of meropenem in children with severe infection
由: Kongthavonsakul K., et al.
出版: (2017)